Zimmer Biomet (ZBH) PT Raised to $153 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St set to open higher as oil slips; telecoms hit by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $88.88 --0%
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 30
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 30
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Zimmer Biomet (NYSE: ZBH) to $153.00 (from $137.00) while maintaining a Hold rating.
You May Also Be Interested In
- Barclays Starts Zimmer Biomet (ZBH) at Equalweight
- LG Household & Health Care Ltd (0519000:KS) (LGHHF) PT Lowered to KRW262,000 at Macquarie
- PPG Industries (PPG) PT Lowered to $128 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
